• Home
  • Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model.

Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model.

Author List
Dong M, Liu X, Evert K, Utpatel K, Peters M, Zhang S, Xu Z, Che L, Cigliano A, Ribback S, Dombrowski F, Cossu A, Gordan J, Calvisi DF, Evert M, Liu Y, Chen X
Publication
Cell death & disease
Publication ID (Profile URL)
https://researcherprofiles.org/profile/14543012
Publication Year
2018
PubMed ID
29348467
Publication Title
Dong M, Liu X, Evert K, Utpatel K, Peters M, Zhang S, Xu Z, Che L, Cigliano A, Ribback S, Dombrowski F, Cossu A, Gordan J, Calvisi DF, Evert M, Liu Y, Chen X. Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model. Cell Death Dis. 2018 01 18; 9(2):31.